FI916017A0 - Menetelmä terapeuttisesti käyttökelpoisten amino- ja nitrosubstituoitujen trisyklisten yhdisteiden valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten amino- ja nitrosubstituoitujen trisyklisten yhdisteiden valmistamiseksi

Info

Publication number
FI916017A0
FI916017A0 FI916017A FI916017A FI916017A0 FI 916017 A0 FI916017 A0 FI 916017A0 FI 916017 A FI916017 A FI 916017A FI 916017 A FI916017 A FI 916017A FI 916017 A0 FI916017 A0 FI 916017A0
Authority
FI
Finland
Prior art keywords
nitro
preparation
hydrogen
therapeutically useful
amino
Prior art date
Application number
FI916017A
Other languages
English (en)
Swedish (sv)
Other versions
FI95800C (fi
FI916017A (fi
FI95800B (fi
Inventor
Gary Alan Flynn
Douglas Wade Beight
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI916017A0 publication Critical patent/FI916017A0/fi
Publication of FI916017A publication Critical patent/FI916017A/fi
Application granted granted Critical
Publication of FI95800B publication Critical patent/FI95800B/fi
Publication of FI95800C publication Critical patent/FI95800C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI916017A 1990-12-21 1991-12-19 Menetelmä terapeuttisesti käyttökelpoisten amino- ja nitrosubstituoitujen trisyklisten yhdisteiden valmistamiseksi FI95800C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US63357290A 1990-12-21 1990-12-21
US63357290 1990-12-21
US77762591A 1991-10-23 1991-10-23
US77762591 1991-10-23

Publications (4)

Publication Number Publication Date
FI916017A0 true FI916017A0 (fi) 1991-12-19
FI916017A FI916017A (fi) 1992-06-22
FI95800B FI95800B (fi) 1995-12-15
FI95800C FI95800C (fi) 1996-03-25

Family

ID=27091923

Family Applications (1)

Application Number Title Priority Date Filing Date
FI916017A FI95800C (fi) 1990-12-21 1991-12-19 Menetelmä terapeuttisesti käyttökelpoisten amino- ja nitrosubstituoitujen trisyklisten yhdisteiden valmistamiseksi

Country Status (18)

Country Link
EP (1) EP0492369B1 (fi)
JP (1) JP3112327B2 (fi)
KR (2) KR100220880B1 (fi)
CN (1) CN1040985C (fi)
AT (1) ATE158303T1 (fi)
AU (1) AU642321B2 (fi)
CA (1) CA2057786C (fi)
DE (1) DE69127681T2 (fi)
DK (1) DK0492369T3 (fi)
ES (1) ES2108027T3 (fi)
FI (1) FI95800C (fi)
GR (1) GR3025622T3 (fi)
HU (1) HU210167B (fi)
IE (1) IE914507A1 (fi)
IL (1) IL100416A (fi)
NO (1) NO180196C (fi)
NZ (1) NZ241023A (fi)
PT (1) PT99849B (fi)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308841A (en) * 1990-12-21 1994-05-03 Merrell Dow Pharmaceuticals Inc. Amino and nitro containing tricyclic compounds useful as inhibitors of ACE
US5457196A (en) * 1991-09-27 1995-10-10 Merrell Dow Pharmaceuticals Inc. 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
ES2106112T3 (es) * 1991-09-27 1997-11-01 Merrell Pharma Inc Derivados de indano-2-mercaptoacetilamida con una actividad inhibidora de encefalinasa y de ace.
AU657793B2 (en) * 1991-09-27 1995-03-23 Merrell Pharmaceuticals Inc. Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
ZA927211B (en) * 1991-09-27 1993-03-24 Merrell Dow Pharma Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE.
US5455242A (en) * 1991-09-27 1995-10-03 Merrell Dow Pharmaceuticals Inc. Carboxyalkyl tricyclic derivatives useful as inhibitors of enkephalinase and ace
ES2138622T3 (es) * 1992-05-15 2000-01-16 Merrell Pharma Inc Derivados de mercaptoacetilamido piridazo(1,2-a)(1,2)diazepina utilizados como inhibidores de encefalinasa y eca.
HUT71243A (en) * 1992-10-30 1995-11-28 Merrell Pharma Inc Mercaptoacetylamide bicyclic lactam derivatives, process for producing them and pharmaceutical compositions of enkephalinase and ace inhibitor activity containing said compounds
US5362727A (en) * 1993-07-26 1994-11-08 Bristol-Myers Squibb Substituted azepino[2,1-a]isoquinoline compounds
US5525723A (en) * 1993-11-18 1996-06-11 Bristol-Myers Squibb Co. Compounds containing a fused multiple ring lactam
US5530013A (en) * 1994-02-14 1996-06-25 American Home Products Corporation Venlafaxine in the inducement of cognition enhancement
EP0745080B1 (en) * 1994-02-14 1999-03-03 Merrell Pharmaceuticals Inc. Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
JPH09508906A (ja) * 1994-02-14 1997-09-09 メレル ファーマスーティカルズ インコーポレーテッド エンケファリナーゼ及びａｃｅの阻害剤として有用な新規なメルカプトアセチルアミド１，３，４，５−テトラヒドロベンゾ［ｃ］アゼピン−３−オンジスルフィド誘導体類
WO1995021857A1 (en) * 1994-02-14 1995-08-17 Merrell Pharmaceuticals Inc. Novel 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
WO1995021840A1 (en) * 1994-02-14 1995-08-17 Merrell Pharmaceuticals Inc. Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
US5484783A (en) * 1994-03-24 1996-01-16 Merrell Dow Pharmaceuticals Inc. Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide and benzazapine derivatives
ATE246927T1 (de) * 1994-03-24 2003-08-15 Merrell Pharma Inc Cholesterin senkende mercaptoacetylamiddisulfidderivate
CN1144487A (zh) * 1994-03-24 1997-03-05 默里尔药物公司 降低胆固醇、抗动脉粥样硬化和降低甘油三酯的巯基乙酰胺衍生物
ES2216386T3 (es) * 1994-12-21 2004-10-16 Aventis Pharmaceuticals Inc. Nuevos procesos de preparacion de productos intermedios de inhibidores de la enzima que convierte la encefalinasa y la angiotensina, y sus productos intermedios.
US5641880A (en) * 1994-12-21 1997-06-24 Hoechst Marion Roussel, Inc. Processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
US7078225B2 (en) 2000-06-02 2006-07-18 Nippon Shokubai Co., Ltd. Method for enzymatically producing an optically active cyanohydrin
GB0119305D0 (en) 2001-04-12 2001-10-03 Aventis Pharma Gmbh Mercaptoacetylamide derivatives,a process for their preparation and their use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4584294A (en) * 1984-11-07 1986-04-22 Merck & Co., Inc. Fused tricyclic lactams as angiotensin converting enzyme inhibitors and as antihypertensive agents
ZA874107B (fi) * 1986-06-13 1987-12-09
AU636101B2 (en) * 1987-04-10 1993-04-22 Monash University 1,2,3,4,10,14b-hexahydrodibenzo(c,f)pyrazino-(1,2-a)azepino derivatives and 10-aza, 10-oxa and 10-thia analogues
US4824832A (en) * 1987-12-30 1989-04-25 Merrell Dow Pharmaceuticals Inc. Sulfhydryl containing tricyclic lactams and their pharmacological methods of use
CA2053340C (en) * 1990-10-18 2002-04-02 Timothy P. Burkholder Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace

Also Published As

Publication number Publication date
CA2057786A1 (en) 1992-06-22
IL100416A (en) 1995-11-27
AU642321B2 (en) 1993-10-14
HUT60271A (en) 1992-08-28
ATE158303T1 (de) 1997-10-15
AU8981991A (en) 1992-06-25
KR920012082A (ko) 1992-07-25
EP0492369B1 (en) 1997-09-17
CN1040985C (zh) 1998-12-02
DK0492369T3 (da) 1997-10-13
EP0492369A1 (en) 1992-07-01
FI95800C (fi) 1996-03-25
ES2108027T3 (es) 1997-12-16
GR3025622T3 (en) 1998-03-31
KR100220879B1 (ko) 2000-03-15
NO180196C (no) 1997-03-05
NO180196B (no) 1996-11-25
JP3112327B2 (ja) 2000-11-27
NO915068D0 (no) 1991-12-20
DE69127681T2 (de) 1998-01-15
HU210167B (en) 1995-02-28
NO915068L (no) 1992-06-22
JPH04342588A (ja) 1992-11-30
KR100220880B1 (ko) 1999-09-15
HU914092D0 (en) 1992-03-30
FI916017A (fi) 1992-06-22
CA2057786C (en) 2002-06-18
FI95800B (fi) 1995-12-15
IE914507A1 (en) 1992-07-01
NZ241023A (en) 1994-10-26
IL100416A0 (en) 1992-09-06
DE69127681D1 (de) 1997-10-23
PT99849A (pt) 1992-11-30
PT99849B (pt) 1999-06-30
CN1062729A (zh) 1992-07-15

Similar Documents

Publication Publication Date Title
FI95800B (fi) Menetelmä terapeuttisesti käyttökelpoisten amino- ja nitrosubstituoitujen trisyklisten yhdisteiden valmistamiseksi
TR199601032A2 (tr) Matris metalloprotaz önleyicileri.
EA199900591A1 (ru) АЗОТСОДЕРЖАЩИЕ ГЕТЕРОАРОМАТИЧЕСКИЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ ФАКТОРА Ха
DK0759899T3 (da) Nitroforbindelser og sammensætninger deraf med antiinflammatoriske, analgetiske og antitrombotiske aktiviteter
MY107756A (en) Piperazine derivatives.
DK359289A (da) 4-oxoquinolin-3-carboxylsyrederivater og fremgangsmaade til fremstilling deraf samt deres anvendelse
EE200200070A (et) Raku adhesiooni inhibiitorid
DK1113011T3 (da) Aminotetrazol-derivater, der er anvendelige som nitrogenoxidsynthaseinhibitorer
MXPA04005940A (es) Acidos 3-(imidazolil)-2-aminopropanoicos.
ES8603809A1 (es) Un procedimiento para preparar un derivado de fluoralilamina
AU5296199A (en) Antibacterial agents
NO972731D0 (no) Thiazolidinonforbindelser eller middel inneholdende disse for å behandle eller forhindre angina pectoris
CO4230083A1 (es) Novedosos carbomatos y ureas como modificaciones a la resis- tencia a multiples drogas
NO912420L (no) Antiatherosklerotiske og antitrombotiske 1-benzopyran-4-oner og 2-amino-1,3-benzoksazin-4-oner.
ATE44741T1 (de) 2-(n-substituierte guanidino)-4heteroarylthiazole als mittel gegen geschwuere.

Legal Events

Date Code Title Description
FG Patent granted

Owner name: MERRELL DOW PHARMACEUTICALS INC.

BB Publication of examined application